MedPath

南京新百药业有限公司

Ownership
-
Established
2001-03-28
Employees
-
Market Cap
-
Website
http://www.njxbyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

72

NMPA:72

Drug Approvals

Carboprost Tromethamine Injection

Product Name
卡前列素氨丁三醇注射液
Approval Number
国药准字H20244628
Approval Date
Aug 5, 2024
NMPA

Vecuronium Bromide for Injection

Product Name
注射用维库溴铵
Approval Number
国药准字H20067267
Approval Date
Nov 26, 2020
NMPA

Compound Ossotide Injection

Product Name
复方骨肽注射液
Approval Number
国药准字H32020003
Approval Date
Nov 26, 2020
NMPA

Gatifloxacin for Injection

Product Name
哲朋
Approval Number
国药准字H20061146
Approval Date
Nov 26, 2020
NMPA

Compound Ossotide Injection

Product Name
复方骨肽注射液
Approval Number
国药准字H32020004
Approval Date
Nov 26, 2020
NMPA

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H32025282
Approval Date
Sep 28, 2020
NMPA

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H32025281
Approval Date
Sep 28, 2020
NMPA

Oxytocin Injection

Product Name
缩宫素注射液
Approval Number
国药准字H32025280
Approval Date
Sep 28, 2020
NMPA

Ocular Extractives Injection

Product Name
眼氨肽注射液
Approval Number
国药准字H32025781
Approval Date
Sep 2, 2020
NMPA

Hyodeoxycholic Acid

Product Name
猪去氧胆酸
Approval Number
国药准字H32024651
Approval Date
Sep 2, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.